Evidence map›Paper›PMID 42327914›Full record

ArticleInorganic chemistry frontiers2026

Picolinamide-functionalized macrocyclic chelators for

Bradley E Osborne, Christina Siakalli, Ryan K Brown, Andrew J P White, Claudia Rocco, Dominik Weiss, Estefanía Delgado-Pinar, Enrique García-España, Jane K Sosabowski, Michelle T Ma and 1 more

Abstract read
In one paragraph

Article in Inorganic chemistry frontiers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Bradley E OsborneDepartment of Chemistry, Imperial College London, Molecular Sciences Research Hub White City Campus London W12 0BZ UK n.long@imperial.ac.uk b.osborne18@imperial.ac.uk.ORCID https://orcid.org/0000-0001-9663-8292
Christina SiakalliDepartment of Chemistry, Imperial College London, Molecular Sciences Research Hub White City Campus London W12 0BZ UK n.long@imperial.ac.uk b.osborne18@imperial.ac.uk.ORCID https://orcid.org/0000-0002-5505-5303
Ryan K BrownDepartment of Chemistry, Imperial College London, Molecular Sciences Research Hub White City Campus London W12 0BZ UK n.long@imperial.ac.uk b.osborne18@imperial.ac.uk.
Andrew J P WhiteDepartment of Chemistry, Imperial College London, Molecular Sciences Research Hub White City Campus London W12 0BZ UK n.long@imperial.ac.uk b.osborne18@imperial.ac.uk.
Claudia RoccoDepartment of Earth Science and Engineering, Imperial College London South Kensington Campus London SW7 2BP UK.
Dominik WeissDepartment of Earth Science and Engineering, Imperial College London South Kensington Campus London SW7 2BP UK.
Estefanía Delgado-PinarInstitute of Molecular Sciences, Universitat de València València Spain.
Enrique García-EspañaInstitute of Molecular Sciences, Universitat de València València Spain.ORCID https://orcid.org/0000-0002-4601-6505
Jane K SosabowskiCentre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London London UK.
Michelle T MaSchool of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital 4th Floor Lambeth Wing London SE1 7EH UK.ORCID https://orcid.org/0000-0002-3349-7346
Nicholas J LongDepartment of Chemistry, Imperial College London, Molecular Sciences Research Hub White City Campus London W12 0BZ UK n.long@imperial.ac.uk b.osborne18@imperial.ac.uk.ORCID https://orcid.org/0000-0002-8298-938X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Picolinamide-functionalized macrocyclic ligands represent a promising class of chelators for

Identifiers

PMID42327914
PMCPMC13277825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.